Market Research Report
Malaria Diagnostics Market Size, Share & Trends Analysis Report By Technology (RDTs, Microscopy, Molecular Diagnostic Tests), By Region (Eastern Mediterranean, Southeast Asia, Africa), And Segment Forecasts, 2019 - 2026
|Published by||Grand View Research, Inc.||Product code||358111|
|Published||Content info||84 Pages
Delivery time: 2-3 business days
|Malaria Diagnostics Market Size, Share & Trends Analysis Report By Technology (RDTs, Microscopy, Molecular Diagnostic Tests), By Region (Eastern Mediterranean, Southeast Asia, Africa), And Segment Forecasts, 2019 - 2026|
|Published: June 19, 2019||Content info: 84 Pages||
The global malaria diagnostics market size is projected to reach USD 998.85 million by 2026 expanding at a CAGR of 5.4%, according to a new report by Grand View Research, Inc. Rising prevalence of the tropical disease in endemic countries, development of novel diagnostic techniques, and rising investments by regional governments and private investors are expected to propel market growth. Malaria is one of the most widespread life-threatening diseases, commonly occurring in the tropical and subtropical regions due to changing climate, low economic growth, underdeveloped healthcare infrastructure, and lack of access to advanced treatment.
Increasing number of government initiatives and investments by market participants are also anticipated to fuel market growth in the near future. A large number of malarial elimination programs are being undertaken by major companies to reduce the disease prevalence. For instance, Novartis's Malaria Initiative was aimed at facilitating malaria elimination and control.Along with various organizations, the company has provided non-profit treatment to 750 million people across 60 countries. Thus, such initiatives are anticipated to facilitate the development of novel technologies and aid in market penetration.
Few key companies include: Access Bio, Inc.; Alere, Inc.; Premier Medical Corporation Ltd.; Sysmex Partec GmbH; bioMerieux, Beckman Coulter, Inc.; Siemens Healthcare; and Leica Microsystems